Press Releases

Toronto, ON and  New York, NY – September 25, 2025 – RamSoft Inc., a global leader in cloud-based RIS/PACS radiology solutions, has announced a new distributorship agreement with Koios Medical, developer of Smart Ultrasound™, an AI-powered clinical decision support solution for breast and thyroid cancer detection and diagnosis. Through this partnership, Koios AI software will be fully integrated into RamSoft’s cloud-native RIS/PACS platforms, giving RamSoft customers access to a powerful new toolkit to strengthen their imaging programs.

Koios Smart Ultrasound™ is built on ensembles of algorithms trained with a proprietary diverse dataset of over 2 million ultrasound images. By analyzing 17,900 features per image, the AI provides an accurate and reimbursement eligible cancer risk assessment that helps physicians and technologists classify lesions with greater precision. Clinical and operational results show that Koios DS enables clinics to see an average of up to 30% more patients per day, achieve 49% less interpretation time, and deliver a 100-400% return on investment to customers —all while supporting earlier disease detection, avoidance of costly downstream procedures and treatments and improved patient outcomes.

With Koios now available directly through RamSoft, customers gain the ability to expand their Women’s Health offerings with seamless AI integration—without added technical complexity or integration costs. This collaboration marks a key addition to RamSoft’s growing portfolio of 15+ integrated AI applications.

“We are excited that, now as an integrated partner, our Koios solution will be easily accessible to RamSoft’s large and growing user base of radiologists and imaging practices,” said Chad McClennan, President & CEO of Koios Medical. “Our collaboration means that RamSoft customers can quickly access and benefit from increased detection accuracy and automated ultrasound reporting enabled by Koios for breast and thyroid imaging procedures today, and more in the future—without added complexity or integration costs. In the U.S., practices can immediately benefit from the reimbursement pathway available to them for Koios procedures.”

“Koios adds significant value to RamSoft’s comprehensive Women’s Health portfolio, which offers a wide suite of AI and reporting tools integrated into our cloud-based RIS/PACS platforms,” said Vijay Ramanathan, Co-Founder & CEO of RamSoft. “Koios provides our customers a powerful AI platform that complements breast and thyroid ultrasound procedures, which are so critical in the assessment of cancer.”

‍

RamSoft Women’s Health Portfolio

With the addition of Koios, RamSoft’s Women’s Health portfolio now includes:

• Stana™ breast tracking and reporting platform,
• iCAD’s Profound AI® 2D and AI-based FDA-cleared cancer detection and density platform,
• Therapixel’s MammoScreen® 2D & 3D FDA-cleared, comprehensive breast cancer screening AI-solution, and
• Ikonopedia web-based breast reporting and tracking platform, including BI-RADS® compliant structured reporting.

‍

About RAMSOFT
RamSoft is a global provider of innovative cloud-based radiology software solutions for imaging centers, radiology departments, and teleradiology providers. PowerServer™, utilized by over 750 sites and thousands of customers worldwide, offers a flexible, scalable design enabling imaging operations of all sizes to leverage comprehensive cloud-based RIS (Radiology Information System)/PACS (Picture Archiving and Communication System) capabilities. RamSoft’s latest offering, OmegaAI®, is a cloud-native AI-driven platform delivering rapid, secure, and robust RIS and PACS capabilities that are completely zero footprint, powered by Microsoft Azure. Additionally, Blume™ - Patient Portal allows patients to access, store& share their diagnostic imaging studies with referring physicians, family members & for their personal records.

About Koios Medical
Koios Medical harnesses the power of artificial intelligence algorithms to support early detection and accurate treatment of disease. Its reimbursement eligible technology is proven to reduce inaccurate readings and eliminate false positives. Koios DS™ Breast is the only FDA-cleared AI cancer diagnosis software for breast ultrasound images and works with the physician as an expert on-demand second opinion for classifying suspicious lesions and aligning to a BI-RADS® category, while automatically prepopulating diagnostic reports. KoiosDS™ Thyroid supports thyroid cancer diagnosis and, along with Koios DS, can be deployed directly on ultrasound scanners or connected to any PACS. These solutions provide feedback useful for diagnosis and decision support while streamlining workflow. For more information, visit www.koiosmedical.com.

Media Contacts:

Rob Sandler
Chief Marketing Officer
RamSoft
+1647-361-4516
rob.sandler@ramsoft.com
www.ramsoft.com‍

Tonja Haugh
Chief Owl Evangelist
Koios Medical, Inc
+1 716-574-2165
thaugh@koiosmedical.com
www.koiosmedical.com

‍